Preventing aortic growth with shape-memory polymer treatment
Part of Heart & circulation clinical trials.
This trial tests a new device made of shape-memory polymer that is placed into the false lumen (abnormal blood channel) of an aortic dissection to block blood flow and prevent the aorta from growing. It's for people with type B aortic dissections who either haven't had treatment for the primary tear yet, or have had that tear treated but now need to address the false lumen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You have a type B aortic dissection (tear in the aorta) that has not been treated before, or you've had treatment for the primary tear and now need treatment for the remaining false lumen.
- Your dissection must be at least 15 days old (not in the acute phase).
- You have not had prior treatment for the false lumen.
- You are not pregnant, not planning to become pregnant, and will use birth control if needed.
- You are willing to attend follow-up visits and have a life expectancy of at least 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device made of a special material that is injected into the false lumen (an abnormal channel) of an aortic dissection to prevent the aorta from growing larger. It is for people with a type B aortic dissection who have not been treated before or who have had prior treatment and now need further help.
This trial tests a new polymer device to close the false lumen (an extra channel) in the aorta for people with type B aortic dissection. It may prevent the aorta from growing and reduce the risk of complications.
This trial tests a new device (WeFlow-EndoPatch) to seal small tears in the aorta after previous dissection repair. It may be an option if you have 1 or 2 small tears in your descending aorta and are generally healthy enough for a catheter procedure.
This trial studies which treatment is best for people with a recent, “uncomplicated” type B aortic dissection (a tear in the aorta). It may help doctors choose safer care for patients whose dissection has not yet caused major complications.
This trial tests a special stent graft for people with a type B aortic dissection that needs a new blood flow path to the left subclavian artery. The device is placed in the aortic arch to repair the tear and keep blood flowing normally.
This study tests whether repairing an enlarged or tearing (dissection) thoracic aorta using a catheter-based procedure can be safer for people who are high-risk for open surgery. It uses specialized stent grafts placed through blood vessels to seal the problem and prevent complications.
Hear when a new Aortic Dissection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.